Lupus-Type "Anticoagulant" in a Dog With Hemolysis and Thrombosis

A circulating anticoagulant was detected in a 2-year-old Chesapeake Bay Retriever with hemolytic anemia, nephrotic syndrome, thrombocytopenia, polyarthropathy, and pulmonary thromboembolism. A persistent prolongation of the activated partial thromboplastin time (aPTT) was detected, and it did not correct with repeated administration of fresh frozen plasma. The aPTT was still prolonged, with a 1:1 mixture of patient's plasma and normal dog plasma in vitro, suggesting the presence of a circulating inhibitor. Results of assays to characterize the inhibitor were compatible with those described for the lupus anticoagulant in human patients with systemic lupus erythematosus. Paradoxically, patients having the lupus anticoagulant are at increased risk for thrombosis. Pulmonary thromboembolism has been described as a frequent complication of immune-mediated hemolytic anemia in the dog, and the presence of a circulating anticoagulant should be considered as a potential mechanism.     

Season-specific varietal management as an option to increase rainfed lowland rice production in East African high altitude cropping systems

Due to land expansion and an increase in productivity, rice production in sub-Saharan Africa has been growing at a rate of 6% in the past decade. Rainfed rice production systems have accounted for a large share of this expansion. In these systems, the potential growing period not only depends on the length of the rainy season and thus water availability, but is often, especially in the highlands of East Africa, bordered by the onset of the cool period of the year, when low minimum temperatures compromise rice yields. The objective of this study was to investigate the yield potential of 30 rice varieties contrasting in crop duration and cold tolerance in the highlands of East Africa, with its limited length of growing period. A field trial was conducted in the cropping seasons in 2016 and 2017 at the Fogera rice research station, Ethiopia. As a function of the onset of rains, rice was sown mid-July in 2016 and early July in 2017. Early sowing in 2017 led to an extended crop duration and significantly lower yields of the short-duration varieties, and to a shortened duration and significantly higher yields of the medium- and long-duration varieties, when compared to late sowing in 2016. Late sowing compromised yield of the medium- and long-duration varieties because of low temperatures during booting stage, which led to high spikelet sterility. Early sowing resulted in low yields of the short-duration varieties, probably due to low solar radiation during the cloudy rainy season, which coincided with the vegetative stage. Therefore, choice of variety should be a function of the variable onset of the rainy season and related sowing date. However, crop models precisely calibrated for potential varieties and the respective environmental conditions could fully support the selection of a suitable variety, depending on the date of sowing, for example with the help of online tools or smartphone applications.     

Reforming the European Common Fisheries Policy: a case for capacity and effort controls

I summarize the total allowable catch (TAC) fishery management system, which forms part of the European Common Fisheries Policy (CFP) as complicated, inaccurate and ineffective. Total allowable effort (TAE), i.e. limits on fishing capacity and days‐at‐sea, provides a simpler, readily enforceable control to protect all species affected by a fishery. Fishing capacity of vessels in each region‐gear fleet could be capped through limits on engine power, gear, crew, and fittings, and/or reducing allowances of days‐at‐sea for large, powerful vessels. Two basic, fishery‐dependent indicators are put forward to assess sustainability of a fishery dependably even in the absence of fishery‐independent data. One is socio‐economic, the other is ecological. Fishery working groups within each marine region would recommend a TAE to sustain their fishery while also protecting the most critically affected species or processes. Regional working groups would supervise a consistent approach across the different fisheries in their region. A pan‐European group would set policy, implement external agreements, set rules for trading TAE if necessary and harmonize fishing opportunities across regions. To ease negotiations on TAEs with the fishing industry when an ecosystem needs to recover, I propose compensation payments funded by re‐direction of existing CFP subsidies that promote fishing.     

Hemophilia A in three unrelated cats

Factor VIII deficiency, consistent with hemophilia A, was detected in 3 unrelated male domestic short-haired cats. Clinical history of each case differed and illustrated the spectrum of clinical manifestations of this disease in cats. Clinical expression of feline hemophilia A was similar to that of man and other animals, in which the degree of factor VIII deficiency tends to determine the severity and frequency of bleeding. All 3 cats had severe protracted bleeding after minor surgical procedures. Hemorrhage was eventually controlled in each case by transfusions of fresh whole blood.     

A Combination Chemotherapy Protocol (VELCAP-L) for Dogs with Lymphoma

Ninety-eight dogs with lymphoma treated with a 5-drug combination chemotherapy regimen (vincristine, L-asparaginase. cyclophosphamide, doxorubicin, prednisone [VELCAP-L]) were evaluated for pretreatment characteristics predictive for response and remission duration. The complete remission rate was 69%, with a median remission duration of 55 weeks. Dogs with advanced stage of disease, constitutional signs, dogs that were older, and dogs that were dyspneic were less likely to achieve remission. Once in remission, small dogs and dogs without pretreatment thrombocytopenia were likely to have longer remission duration. Toxicoses were frequent, but rarely fatal, and no predictitive factors were found for a dog developing toxicoses. VELCAP-L is an effective treatment for dogs in stage I-III lymphoma, particularly in young, small animals.     

Marine Pseudovibrio sp. as a Novel Source of Antimicrobials

Antibiotic resistance among pathogenic microorganisms is becoming ever more common. Unfortunately, the development of new antibiotics which may combat resistance has decreased. Recently, however the oceans and the marine animals that reside there have received increased attention as a potential source for natural product discovery. Many marine eukaryotes interact and form close associations with microorganisms that inhabit their surfaces, many of which can inhibit the attachment, growth or survival of competitor species. It is the bioactive compounds responsible for the inhibition that is of interest to researchers on the hunt for novel bioactives. The genus Pseudovibrio has been repeatedly identified from the bacterial communities isolated from marine surfaces. In addition, antimicrobial activity assays have demonstrated significant antimicrobial producing capabilities throughout the genus. This review will describe the potency, spectrum and possible novelty of the compounds produced by these bacteria, while highlighting the capacity for this genus to produce natural antimicrobial compounds which could be employed to control undesirable bacteria in the healthcare and food production sectors.     

Cytosine Arabinoside as a Single Agent for the Induction of Remission in Canine Lymphoma

Cytosine arabinoside (AraC) was administered as a continuous IV infusion to 15 dogs with malignant lymphoma at a dose of 300 mg/m²/d for 2 consecutive days. Dogs were re-examined 7 d after treatment for response to therapy and for hematologic toxicity. Regardless of response, all dogs were started on combination chemotherapy at this time. Other toxicities were reported by owners. No dog responded objectively to Ara-C treatment, although 1 dog with circulating lymphoblasts had partial regression of lymphadenopathy but persistent blastemia. Thrombocytopenia (platelet count < 200,000/μL) 7 days posttreatment was the most commonly encountered hematologic toxicity, occurring in 10 of 14 dogs. Three of these 10 dogs were also mildly neutropenic (neutrophil counts of 2000 to 3000 cell/μL). Nonhematologic toxicity occurred in 8 of 15 dogs and was principally gastrointestinal in nature and mild in severity. Cytosine arabinoside at a dose of 300 mg/m²/day was not considered an active drug for the induction of remission in dogs with lymphoma.     

Preserving new anthelmintics: a simple method for estimating faecal egg count reduction test (FECRT) confidence limits when efficacy and/or nematode aggregation is high

As it has been 30 years since a new anthelmintic class was released, it is appropriate to review management practices aimed at slowing the development of anthelmintic resistance to all drug classes. Recommendations to delay anthelmintic resistance, provide refugia and the use of a simulation model were reviewed to find optimum treatment strategies that maintain nematode control. Simulated Australian conditions indicated that a common successful low-risk treatment program was a rapid rotation between a "triple-combination" product (benzimidazole+levamisole+abamectin) and a new high-efficacy drug (monepantel). Where Haemonchus contortus was a threat, moxidectin was required at critical times because of its persistent activity against this parasite. Leaving up to 4% of adult sheep untreated provided sufficient "refugia" for non-selected worms to reduce the risk of selecting for anthelmintic resistance without compromising nematode control. For a new anthelmintic, efficacy estimated by faecal egg count reduction (FECR) is likely to be at or close to 100%, however using current methods the 95% confidence limits (CL) for 100% are incorrectly determined as 100%. The fewer eggs counted pre-treatment, the more likely an estimate of 100% will occur, particularly if the true efficacy is >90%. A novel way to determine the lower-CL (LCL) for 100% efficacy is to reframe FECR as a binomial proportion, i.e. define: n and x as the total number of eggs counted (rather than eggs per gram of faeces) for all pre-treatment and post-treatment animals, respectively; p the proportion of resistant eggs is p = x/n and percent efficacy is 100 ×(1-p) (assuming equal treatment group sizes and detection levels, pre- and post-treatment). The LCL is approximated from the cumulative inverse beta distribution by: 95%LCL=100 ×(1-(BETAINV(0.975, x+1, n-x+1))). This method is simpler than the current method, independent of the number of animals tested, and demonstrates that for 100% efficacy at least 37 eggs (not eggs per gram) need to be counted pre-treatment before the LCL can exceed 90%. When nematode aggregation is high, this method can be usefully applied to efficacy estimates lower than 100%, and in this case the 95% upper-CL (UCL) can be estimated by: 95% UCL = 100 ×(1((BETAINV(0.025, x+1, n-x+1))), with the LCL approximated as described above. A simulation study to estimate the precision and accuracy of this method found that the more conservative 99%CL was optimum; in this case 0.975 and 0.025 are replaced by 0.995 and 0.005 to estimate the LCL and UCL, respectively.